Market Overview

Benzinga's Top #PreMarket Gainers

Related ICPT
Markets Little Changed Ahead Of 4th Of July Break
Benzinga's Top Initiations
Related SGMO
Events Scheduled for Week of Jun 23rd to Jun 27th, 2014
Sangamo Publishes Preclinical Data Showing Gene Correction in SCID-X1 Human Hematopoietic Stem Cells

Intercept Pharmaceuticals (NASDAQ: ICPT) shares jumped 119.43% to $159.00 in pre-market trading after the company reported that the FLINT trial of obeticholic acid has been stopped early and the NASH primary endpoint has been met.

Sangamo Biosciences (NASDAQ: SGMO) shares gained 13.64% to $15.50 in the pre-market after the company and Biogen Idec (NASDAQ: BIIB) announced the global collaboration to develop treatments for hemoglobinopathies.

Sequenom (NASDAQ: SQNM) surged 10.16% to $2.71 in the pre-market session after the company announced the issuance of European patent for novel methods of detecting fetal aneuploidy.

Macy's (NYSE: M) soared 7.06% to $55.50 in the pre-market trading after the company announced its plans to lower 2,500 jobs and shut five Macy's stores. It also reported a 3.6% rise in its comparable sales in November and December. The retailer also issued upbeat outlook for 2014. BMO Capital upgraded the stock from Market Perform to Outperform and lifted the target price from $53 to $70.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

 

Most Popular

Related Articles (BIIB + ICPT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free